ArticleAging cell2026
A Circadian Trough in Glucocorticoid Signaling Is Essential for Bone Health in Mice.
Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
We previously demonstrated that flattening circadian glucocorticoid (GC) rhythmicity without increasing overall GC exposure induces an osteoporotic phenotype in mice. Here, we aimed to further elucidate the importance of the amplitude and timing of circadian GC oscillations for bone health. C57Bl/6J mice were implanted with vehicle or corticosterone slow-releasing pellets to flatten the circadian GC rhythm. To differentiate between the importance of circadian GC peaks or troughs, mice with flattened GC rhythm received daily CORT injections at the time of the natural GC peak, or glucocorticoid receptor (GR) antagonist (RU486) injections at the time of the trough. One week of flattened GC rhythm reduced serum bone formation marker P1NP levels. Reinstating a trough with RU486 rescued this loss, whereas reinstating a GC peak did not. In an experiment in which mice with flattened GC rhythm received prolonged treatment for 7 weeks with RU486 at Zeitgeber time (ZT) 1 versus 11, we found that P1NP levels peaked with RU486 regardless of time of injection, altogether suggesting that bone formation depends on transient withdrawals from GCs. Seven weeks of flattened CORT rhythm reduced total lean mass and induced cortical bone thinning and trabecular bone loss. RU486 injection at either timepoint prevented cortical bone decline. Notably, trabecular bone volume was only preserved when RU486 was injected at the time of the natural GC trough at ZT1. In conclusion, reinstating a trough in GR signaling at its natural time of the day suffices to prevent osteoporosis in mice under conditions of flattened GC rhythm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.